the cholesterol-lowering effect of clofibrate ( ciba-su13437 ) cholestyramine and the combination of clofibrate and cholestyramine is studied in 19 subjects with type lla hyperlipoproteinaemia , over a 20-week period .
C0008402
cholestyramine
C0020476
hyperlipoproteinaemia